Search
About Us
Specialist Centres
Shop
Contact Us
Articles

October 16, 2022

Obinutuzumab

news about use in TTP

Obinutuzumab

TTPNetwork are proud to have contributed to this paper.
Obinutuzumab elective therapy to prevent immuneThrombotic Thrombocytopenic Purpura (TTP) relapse in patients who are refractory or intolerant to rituximab (adults)

https://www.england.nhs.uk/wp-content/uploads/2023/11/2255-obinutuzumab-cc-policy.pdf?fbclid=IwAR0L_BEU4m0x8uRKi2s-f5dbj9WnZEve7yvrlLDFvv25_UvPIvZ2b8hJZKc

Download/s

Share this post

Similar news

Articles

Patient Designs TShirt for TTP

TTP Patient has designed a T shirt to raise funds for TTPNetwork

Articles

New Item: Sophies Story

One year ago Sophie was diagnosed with TTP at the time she gave birth to her beautiful and much longed for son. Read Sophie's story by clicking below.

Articles

National TTP Psychology Team

Details of the Psychology Team who are working with the TTP Specialist Centres